Medtech Acquisition Corp-cw (TLSIW) — Who's Buying and Selling (13F, Q2 2026)

TLSIW ranks #11881 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

5 institutions disclose a position in TLSIW, but none treat it as a major bet — even Cerity Partners LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Cerity Partners LLC has trimmed its TLSIW position for two straight quarters, cutting it by $711.7K while still holding $662.1K.

TLSIW reported a net loss of $28.2M over the trailing twelve months.

• Not yet profitable — net loss of $28.2M over the trailing twelve months
• Revenue grew 25.2% year over year
• Net income improved year over year, from -$31.2M to -$28.2M
• Operating cash flow was negative, using $18.0M in cash
• Current ratio of 2.80x — enough short-term assets to cover short-term liabilities